Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Dr. Reddy’s Laboratories Announces the First Generic Launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market
Biospace News
-
February 27, 2020
Launch
Abbott launches quadrivalent vaccine for influenza in India ...
Launch
AstraZeneca’s Subsidiary Launches Qtern Tablets for Type 2 Diabetes Treatment in India ...
Launch
AstraZeneca’s Subsidiary Launches Qtern Tablets for Type 2 Diabetes Treatment in India ...
Launch
ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program
Launch
VIVUS Announces Commercial Launch of Qsymia in the Republic of Korea...
Firstwordpharma News
-
February 19, 2020
0
Launch
VIVUS Announces Commercial Launch of Qsymia in the Republic of Korea...
Firstwordpharma News
-
February 19, 2020
0
Launch
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox
Biospace News
-
February 18, 2020
0
Launch
Ortho Dermatologics Launches Telemedicine on Dermatology.com, U.S. Cash-Pay Prescription Program
Firstwordpharma News
-
February 18, 2020
0
Launch
Saniona co-founds new migraine therapy company Cephagenix
Firstwordpharma News
-
February 18, 2020
0
1
2
3
...
19
Page 1 of 19
- Advertisement -
MOST POPULAR
J&J, Bayer to Pay $775 Million to Settle Xarelto Lawsuits
March 26, 2019
With $1.5 Million Donation From Bayer, Gateway Region YMCA Marks Expansion,...
December 16, 2019
Novartis Buys The Medicines Company: A $9.7 Billion Gamble on a...
November 25, 2019
Lysogene Reports its Cash Position as of 30 September 2019
November 20, 2019
Load more
HOT NEWS
Deals
Targovax signs clinical collaboration agreement with the Parker Institute for Cancer...
Others
Interview: Clinical Trial Transparency Is Improving, Particularly Among Larger Companies
Commercial
Tonix Pharmaceuticals Announces New European Use Patent for TNX-601
Others
Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange...
